KayoThera, Inc. — Form D

KayoThera, Inc. of Seattle, WA, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-05. The offering totals $750K, of which $750K was reported sold. Industry: Other.

Offering

Filed: 2019-06-05
Form: D
Accession: 0001778725-19-000002
Industry: Other
Exemptions: 06b
Total offering: $750K
Amount sold: $750K
Investors: 1
Date of first sale: 2019-05-29
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-341191

Issuer

Name: KayoThera, Inc.
CIK: 0001778725
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2019
Address: 2815 Eastlake Avenue East, Suite 300, Seattle, WA, 98102
Phone: (908) 731-6610

Officers, directors & promoters (13)

Name	Role	Location
James M Golubieski	Director	Princeton, NJ
George F Heinrich	Director	Princeton, NJ
Yibin Kang	Director	Princeton, NJ
THONG LE	Director	Seattle, WA
THONG LE	Executive Officer	Seattle, WA
Suzanne Rettenmier	Executive Officer	Seattle, WA
Ian Howes	Executive Officer	Seattle, WA
Kendall Mohler	Director	Seattle, WA
Kendall Mohler	Executive Officer	Seattle, WA
Mark Esposito	Director	NY, NY
Mark Esposito	Executive Officer	NY, NY
KEN MOHLER	Director	PRINCETON, NJ
KEN MOHLER	Executive Officer	PRINCETON, NJ

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2023-07-13	D/A	$10.9M	$10.5M
2023-03-31	D/A	$8.0M	$8.0M
2022-03-24	D	$8.0M	$4.0M

More